EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2019 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 1st, 2019 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 28th day of March, 2019, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Charles F. Wagner, Jr. (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 30th, 2017 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 30th, 2017 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 6th day of September, 2017, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Tom Graney (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 23rd, 2017 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 23rd, 2017 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 14th day of November, 2015, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Michael Parini (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 16th, 2016 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 12th day of December, 2014, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and David Altshuler, M.D., Ph.D. (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2015 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 4th, 2015 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 2nd day of December, 2013, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Jeffrey Allan Chodakewitz, M.D. (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2013 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 1st, 2013 Company Industry JurisdictionThis Second Amended and Restated Employment Agreement (this “Agreement”) amends and restates, effective as of the 15th day of November, 2012, that certain Amended and Restated Employment Agreement made and entered into as of the 5th day of February, 2010 (the “Original Agreement”) by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Peter Mueller (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 6th, 2012 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 6th, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 25th day of July, 2012, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Megan Pace (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2012 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 8th, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 11th day of June, 2012, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Kenneth Horton (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2012 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 22nd, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 31st day of January, 2012, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Christiana Stamoulis (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2012 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 22nd, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 26th day of January, 2012, by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and David T. “Ty” Howton (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 3rd, 2010 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 3rd, 2010 Company Industry JurisdictionThis Amended and Restated Employment Agreement (this “Agreement”) amends and restates, effective as of the 5th day of February, 2010, that certain Employment Agreement made and entered into as of the 11th day of February, 2008, as amended by that certain Amendment to Employment Agreement entered into as of the 27th day of December, 2008 (collectively, the “Original Agreement”) by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Peter Mueller (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 19th, 2010 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 19th, 2010 Company Industry JurisdictionAGREEMENT, made and entered into as of the 9th day of December by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (together with its successors and assigns, the “Company”), and Nancy J. Wysenski (the “Executive”).